Israeli researchers at Ben-Gurion University of the Negev (BGU) has identified novel drug candidates based on molecules isolated from probiotic yogurt for combating pathogenic bacteria and for treating various inflammatory conditions, including inflammatory bowel disease (IBD) and COVID-19-related cytokine storms.